Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

To assess the effects of gonadal steroid replacement on bone density in men with osteoporosis due to severe hypogonadism, we measured cortical bone density in the distal radius by 125I photon absorptiometry and trabecular bone density in the lumbar spine by quantitative computed tomography in 21 men with isolated GnRH deficiency while serum testosterone levels were maintained in the normal adult male range for 12-31 months (mean +/- SE, 23.7 +/- 1.1). In men who initially had fused epiphyses (n = 15), cortical bone density increased from 0.71 +/- 0.02 to 0.74 +/- 0.01 g/cm2 (P less than 0.01), while trabecular bone density did not change (116 +/- 9 compared with 119 +/- 7 mg/cm3). In men who initially had open epiphyses (n = 6), cortical bone density increased from 0.62 +/- 0.01 to 0.70 +/- 0.03 g/cm2 (P less than 0.01), while trabecular bone density increased from 96 +/- 13 to 109 +/- 12 mg/cm3 (P less than 0.01). Cortical bone density increased 0.03 +/- 0.01 g/cm2 in men with fused epiphyses and 0.08 +/- 0.02 g/cm2 in men with open epiphyses (P less than 0.05). Despite these increases, neither cortical nor trabecular bone density returned to normal levels. Histomorphometric analyses of iliac crest bone biopsies demonstrated that most of the men had low turnover osteoporosis, although some men had normal to high turnover osteoporosis. We conclude that bone density increases during gonadal steroid replacement of GnRH-deficient men, particularly in men who are skeletally immature.

[1]  H. Orimo,et al.  [Involutional osteoporosis]. , 1991, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[2]  A. Klibanski,et al.  Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. , 1989, Annals of internal medicine.

[3]  C. V. van Kuijk Vertebral bone density in children: effect of puberty. , 1989, Radiology.

[4]  C. Christiansen,et al.  The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. , 1988, The Journal of clinical endocrinology and metabolism.

[5]  J. Butler,et al.  Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. , 1988, The American journal of physiology.

[6]  M. Young,et al.  Male hypogonadism and bone fracture. , 1988, The New England journal of medicine.

[7]  S L Hui,et al.  Sex steroids and bone mass. A study of changes about the time of menopause. , 1987, The Journal of clinical investigation.

[8]  M. Kleerekoper,et al.  Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. , 1987, The Journal of clinical endocrinology and metabolism.

[9]  W. Crowley,et al.  Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism , 1987 .

[10]  A. Klibanski,et al.  Increase in bone mass after treatment of hyperprolactinemic amenorrhea. , 1986, The New England journal of medicine.

[11]  W. Crowley,et al.  Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. , 1986, Annals of internal medicine.

[12]  J. Kopp,et al.  Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. , 1986, The Journal of clinical endocrinology and metabolism.

[13]  R M Neer,et al.  Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. , 1986, JAMA.

[14]  A. Klibanski,et al.  Osteoporosis in men with hyperprolactinemic hypogonadism. , 1986, Annals of internal medicine.

[15]  W G Hamilton,et al.  Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. , 1986, The New England journal of medicine.

[16]  R. Francis,et al.  Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. , 1986, Bone.

[17]  C. Foresta,et al.  Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men , 1985, Journal of endocrinological investigation.

[18]  R M Neer,et al.  Quantitative computed tomography for spinal density measurement. Factors affecting precision. , 1985, Investigative radiology.

[19]  H. Genant,et al.  Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. , 1985, Annals of internal medicine.

[20]  W. Crowley,et al.  The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. , 1985, Recent progress in hormone research.

[21]  H K Genant,et al.  Quantitative computed tomography for prediction of vertebral fracture risk. , 1985, Bone.

[22]  C. Christiansen,et al.  Longitudinal Study of Calcium Metabolism in Male Puberty , 1984, Acta paediatrica Scandinavica.

[23]  W J Bremner,et al.  Bone mineral content of amenorrheic and eumenorrheic athletes. , 1984, The New England journal of medicine.

[24]  J. Bilezikian,et al.  The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. , 1984, The New England journal of medicine.

[25]  H K Genant,et al.  Decreased spinal mineral content in amenorrheic women. , 1984, JAMA.

[26]  R. Horst,et al.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. , 1984, The Journal of clinical endocrinology and metabolism.

[27]  R. Francis,et al.  The effect of estrogen dose on postmenopausal bone loss. , 1984, The New England journal of medicine.

[28]  L. Melton,et al.  Risk factors for spinal osteoporosis in men. , 1983, The American journal of medicine.

[29]  C. Foresta,et al.  Testosterone and Bone Loss in Klinefelter Syndrome , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  A. Hoffman,et al.  Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. , 1982, The New England journal of medicine.

[31]  S. Krane,et al.  Metabolic bone disease: osteoporosis and osteomalacia. , 1981, Disease-a-month : DM.

[32]  C. Christiansen,et al.  BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY , 1981, The Lancet.

[33]  H. Genant,et al.  Spinal mineral loss in oophorectomized women. Determination by quantitative computed tomography. , 1980, JAMA.

[34]  C. Christiansen,et al.  Effect of puberty on rates of bone growth and mineralisation: with observations in male delayed puberty. , 1979, Archives of disease in childhood.

[35]  E. Beckman Estrogen Replacement Therapy I: A 10-Year Prospective Study in the Relationship to Osteoporosis , 1979, Obstetrics and gynecology.

[36]  A. Poznanski,et al.  Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method) , 1977 .

[37]  P. H. Moore,et al.  Synthesis of new steroid haptens for radioimmunoassay. part I. 15β-Carboxyethylmercaptotestosterone-bovine serum albumin conjugate. measurement of testosterone in male plasma without chromatography , 1976, Steroids.

[38]  R. Lindsay,et al.  LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.

[39]  James M. Tanner,et al.  Assessment of skeletal maturity and prediction of adult height : (TW2 method) , 1986 .

[40]  J. Wergedal,et al.  Quantitative histological studies on the pathogenesis of uremic bone disease. , 1974, The Journal of clinical endocrinology and metabolism.

[41]  J. Cameron,et al.  Bone mineral content in normal US whites , 1974 .

[42]  H. DeLuca,et al.  Competitive binding assay for vitamin D and 25-OH vitamin D. , 1971, The Journal of clinical endocrinology and metabolism.

[43]  J A Sorenson,et al.  Precision and accuracy of bone mineral determination by direct photon absorptiometry. , 1968, Investigative radiology.

[44]  N. Wolański Changes in bone density and cortical thickness of the second metacarpal between the ages of 3 and 74 years as a method for investigating bone mineral metabolism. , 1967, Acta anatomica.

[45]  J. Cameron,et al.  MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD. , 1963, Science.

[46]  L. Wilkins Voluntary Medical Care Insurance in the United States , 1949 .